All the news Showing 10 of 62 articles from: Treatment outcomesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hep C Experts Condemn Cochrane Review Dissing Direct Antivirals MedPage Today / 12 hours ago Response to the Cochrane Systematic Review on DAA-Based Treatment of Chronic Hepatitis C EASL / 13 hours ago AASLD Expresses Concern for Cochrane Review of DAAs AASLD / 26 June 2017 Australian Health Organisations refute Cochrane Review Report and affirm efficacy of Direct Acting Antiviral (DAA) therapy for hepatitis C Manual Items / 26 June 2017 Cochrane condemned for 'bizarre' review of new hep C drugs Australian Doctor / 19 June 2017 Experts question Cochrane review of hepatitis C treatment Keith Alcorn / 15 June 2017 A systematic review of hepatitis C direct-acting antiviral (DAA) studies published by the Cochrane Collaboration has been strongly criticised by doctors and advocates for its conclusion that there is no ... “Findings from hepatitis C study should not deter patients from seeking treatment or governments from funding it” says World Hepatitis Alliance World Hepatitis Alliance / 13 June 2017 The Hepatitis C Trust responds to Cochrane review on hepatitis C treatment Hepatitis C Trust / 13 June 2017 'Miracle' hepatitis C drugs costing £30k per patient 'may have no clinical effect' The Guardian / 08 June 2017 Children with hepatitis C respond well to sofosbuvir/ledipasvir Liz Highleyman / 22 April 2017 Almost all children with hepatitis C, aged 6 to 11 years, who were treated with a half-strength tablet of sofosbuvir/ledipasvir were cured, which is important as some of them had advanced liver ... ← First12345...7Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds